Peyton R. Howell
Director · TANDEM DIABETES CARE INC
- 2026
- May 22, 2026
- 1
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Peyton R. Howell files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Mark David Novara - $4K in TNDM purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Peyton R. Howell?
Peyton R. Howell is a corporate insider, tracked as Director of TANDEM DIABETES CARE INC (TNDM). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Peyton R. Howell last file a Form 4?
The only primary Form 4 on record is dated 22 May 2026.